Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Sensio Care ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.3% 1.8% 1.1% 0.7% 4.7% 7.6% 20.3% 20.3%   Credit score (0-100)   56 73 83 94 45 31 5 5   Credit rating   BBB A A AA BBB BB B B   Credit limit (kDKK)   0.0 3.0 133.1 484.6 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,290 4,445 1,974 3,190 1,440 2,930 0.0 0.0   EBITDA   498 2,830 658 1,277 -1,695 -2,155 0.0 0.0   EBIT   494 2,771 497 920 -2,135 -2,744 0.0 0.0   Pre-tax profit (PTP)   482.1 2,701.7 543.5 962.6 -2,141.5 -2,931.4 0.0 0.0   Net earnings   375.9 2,103.6 421.8 750.5 -1,657.9 -2,022.1 0.0 0.0   Pre-tax profit without non-rec. items   482 2,702 544 963 -2,141 -2,931 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   125 177 164 144 1,450 878 0.0 0.0   Shareholders equity total   734 2,337 2,759 3,510 1,852 -170 -1,120 -1,120   Interest-bearing liabilities   401 889 0.0 146 2,979 5,062 1,120 1,120   Balance sheet total (assets)   2,853 5,152 4,971 5,534 5,990 7,494 0.0 0.0   Net Debt   316 811 -1,309 -1,378 2,671 4,378 1,120 1,120     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,290 4,445 1,974 3,190 1,440 2,930 0.0 0.0   Gross profit growth   12.0% 94.1% -55.6% 61.6% -54.9% 103.5% -100.0% 0.0%   Employees   4 4 4 5 6 6 0 0   Employee growth %   0.0% 0.0% 0.0% 25.0% 20.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,853 5,152 4,971 5,534 5,990 7,494 0 0   Balance sheet change%   -5.7% 80.6% -3.5% 11.3% 8.3% 25.1% -100.0% 0.0%   Added value   498.3 2,829.5 658.0 1,277.0 -1,777.3 -2,155.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   121 1,240 73 -140 529 -1,498 -1,936 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.6% 62.3% 25.2% 28.8% -148.3% -93.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.8% 69.2% 11.1% 18.7% -35.3% -39.5% 0.0% 0.0%   ROI %   34.3% 117.2% 16.6% 26.8% -45.3% -54.5% 0.0% 0.0%   ROE %   31.4% 137.0% 16.6% 23.9% -61.8% -43.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   25.7% 45.4% 55.5% 63.4% 30.9% -2.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   63.5% 28.7% -198.9% -107.9% -157.6% -203.1% 0.0% 0.0%   Gearing %   54.6% 38.0% 0.0% 4.2% 160.9% -2,971.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.0% 10.7% 3.9% 28.2% 7.0% 5.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 1.2 1.4 1.9 0.4 0.7 0.0 0.0   Current Ratio   1.3 1.5 1.9 2.4 0.8 0.9 0.0 0.0   Cash and cash equivalent   84.3 78.4 1,308.9 1,523.4 307.8 683.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   608.1 1,242.5 1,534.3 2,126.8 -993.6 -341.4 -560.1 -560.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   125 707 165 255 -296 -359 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   125 707 165 255 -282 -359 0 0   EBIT / employee   123 693 124 184 -356 -457 0 0   Net earnings / employee   94 526 105 150 -276 -337 0 0